The companies that we will target have the potential to be disruptive and primed for explosive growth and that can change the world for the better, while establishing a position of technological dominance. We believe we are well positioned to pursue initial business combination opportunities within our four domains of interest: Planet & Efficient Energy; Brain & Artificial Intelligence; Genetics & Platform Technologies, and Space, Robotics & Physics. We will seek to identify differentiated opportunities. In Europe and the UK, where deep technology and deep science are very strong, enterprise valuations are in many cases currently attractive relative to other global locations. (Incorporated in the Cayman Islands) 

Alice Newcombe-Ellis is our CEO. She is the founding and general partner of Ahren, a London-based investment firm that she established alongside Ahren’s Science Partners in 2017. Alice has over a decade of investing experience, including at TPG Capital LLP (a leading global private equity firm with more than $70 billion of assets under management (“AUM”) as of March 30, 2021) and at Lansdowne Partners LLP (a leading investment firm with more than $11 billion AUM as of November 2020). Alice has had an investing focus predominantly in technology and disruptive healthcare. Alice holds a Double First-Class degree in Mathematics, and Master’s in Mathematics/Physics from the University of Cambridge. Alice was a Fulbright Scholar and a Baker Scholar at Harvard Business School.

 (Note: Ahren Acquisition Corp. upsized its SPAC IPO at pricing on Dec. 14, 2021, to 27.5 million units, up from 25 million, at $10 each to raise $275 million.)